BigHat Biosciences Company

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Technology: Artificial Intelligence, Biotechnology, Medical, Therapeutics
Industry: Early Drug Development
Headquarters: San Carlos, California, United States
Founded Date: 2019-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 24302511
Estimated Revenue: Less than $1M
Last Funding Date: 2021-02-10
Last Funding Type: Series A

Visit Website
info@bighatbio.com​
https://twitter.com/
Register and Claim Ownership